Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement Firms Should Work Toward Sharing GMP Audits – FDA's Williams

This article was originally published in The Tan Sheet

Executive Summary

FDA dietary supplement program official Brad Williams personally endorses the sharing of supplier audit reports to improve firms' compliance with good manufacturing practices.

You may also be interested in...



Convoluted Herbal Requirements Foretell FSMA Complexities

Ingredient importers supplying herbal materials for food and dietary supplement manufacturers will have to consider their downstream customers’ intended uses to comply with FDA regulations under the Food Safety Modernization Act, which are likely to vex many companies.

Convoluted Herbal Requirements Foretell FSMA Complexities

Ingredient importers supplying herbal materials for food and dietary supplement manufacturers will have to consider their downstream customers’ intended uses to comply with FDA regulations under the Food Safety Modernization Act, which are likely to vex many companies.

Interview: Post-FDA, Williams Still Committed To Supplement GMPs

Brad Williams has moved on from FDA’s Division of Dietary Supplement Programs, but he continues to drive industry GMP compliance at NSF International. In an interview, Williams relates what the industry must do to overcome GMP struggles and commends Dan Fabricant’s work as DDSP director.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104939

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel